Entrada Therapeutics Inc
(TRDA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRDA | AZN | AMGN | GILD | BMY |
| Company | Entrada Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.60 | 194.02 | 377.04 | 151.47 | 60.94 |
| High | 11.35 | 195.90 | 377.36 | 151.87 | 61.45 |
| Low | 10.18 | 190.60 | 363.65 | 147.07 | 59.95 |
| Latest | 10.82 | 193.40 | 364.65 | 147.23 | 60.86 |
| Change | +0.27 | +5.39 | -11.17 | -4.45 | +0.09 |
| % Change | +2.56% | +2.87% | -2.97% | -2.93% | +0.15% |
| Volume | 210,800 | 2,726,800 | 3,526,500 | 10,769,200 | 12,082,700 |
| 20-Day Average Volume | 255,015 | 4,703,908 | 3,175,940 | 8,375,865 | 13,648,750 |
| Previous Close | 10.55 | 188.01 | 375.82 | 151.68 | 60.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.04 | 187.37 | 347.51 | 137.27 | 56.49 |
| 20-Day Raw Stochastic | 43.22% | 85.97% | 68.67% | 82.07% | 86.01% |
| 20-Day Relative Strength | 51.69 | 57.53 | 59.93 | 67.25 | 68.42 |
| Weighted Alpha | -0.72 | +37.20 | +31.42 | +48.72 | +24.70 |
| Today's Opinion | 80% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 64% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 64% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.23% since 02/03/26 | +4.93% since 02/03/26 | +7.70% since 02/03/26 | +2.76% since 02/03/26 | +8.70% since 02/03/26 |
| Low | 9.79 on 02/05/26 | 186.32 on 02/04/26 | 342.38 on 02/04/26 | 143.50 on 02/04/26 | 56.43 on 02/04/26 |
| High | 12.05 on 02/04/26 | 195.90 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +7.98% since 01/09/26 | +2.17% since 01/09/26 | +11.82% since 01/09/26 | +21.58% since 01/09/26 | +8.95% since 01/09/26 |
| Low | 9.33 on 01/12/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 12.18 on 01/22/26 | 195.90 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +49.04% since 11/10/25 | +10.54% since 11/10/25 | +12.66% since 11/10/25 | +24.61% since 11/10/25 | +28.78% since 11/10/25 |
| Low | 7.07 on 11/11/25 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 12.18 on 01/22/26 | 195.90 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +108.48% since 08/08/25 | +31.48% since 08/08/25 | +26.51% since 08/08/25 | +23.30% since 08/08/25 | +32.45% since 08/08/25 |
| Low | 4.93 on 08/11/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 12.18 on 01/22/26 | 195.90 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 403,210 | 291,586,208 | 202,371,936 | 188,186,336 | 123,712,712 |
| Shares Outstanding, K | 38,219 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 210,780,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | 65,630,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,610,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -44,130,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | -0.12 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.06 on 11/06/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/26/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.12 | 17.59 | 18.62 | 10.08 |